Duke Cancer Center /ID# 149099

Durham, North Carolina 27710-3000

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Multiple Myeloma

Studies at this site

• A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy — Completed